Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
January 2018
in “
Springer eBooks
”
papulopustular rash folliculitis paronychia xerosis hair modifications anti-EGFR agents maculopapular eruptions pruritus alopecia pigmentary changes hand-foot skin reaction HFSR kit inhibitors bcr-abl inhibitors antiangiogenic agents RAF inhibitors MEK inhibitors mTOR inhibitors rash dry skin hair changes EGFR inhibitors itching hair loss skin color changes hand-foot syndrome KIT inhibitors BCR-ABL inhibitors angiogenesis inhibitors
Studysummary This chapter reviews the skin side effects associated with targeted cancer therapies and emphasizes the importance of collaboration between oncologists and dermatologists without reporting new results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on link.springer.com →